Home FGFR3-related hypochondroplasia: longitudinal growth in 57 children with the p.Asn540Lys mutation
Article
Licensed
Unlicensed Requires Authentication

FGFR3-related hypochondroplasia: longitudinal growth in 57 children with the p.Asn540Lys mutation

  • María Alejandra Arenas EMAIL logo , Mariana del Pino and Virginia Fano
Published/Copyright: October 18, 2018

Abstract

Background

Children with hypochondroplasia (HCH), who have FGFR3 mutations c.1620C>A or c.1620C>G (p.Asn540Lys) appear to have a more severe phenotype than those with HCH without these mutations. We describe the change in height, leg length and body proportions in a retrospective cohort of children with HCH related-p.Asn540Lys mutation and we compared them with Argentine population.

Methods

Anthropometric measurements were initially taken and followed up by the same observer, with standardized techniques. Sitting height/height and head circumference/height ratio were calculated as a body disproportion indicator. In order to make a comparison with the Argentine population height average, centiles of height, leg length and body proportions were estimated by the LMS method.

Results

The sample consisted of 57 HCH children (29 males and 28 females) between the ages of 0–18 years. The median (interquartile range) number of measurements per child was 8 (4.3, 13) for height, 7 (4, 12) for sitting height and 7.5 (4, 12.8) for head circumference. Leg length increased from 17 cm at birth to approximately 54 cm in adolescents, 25 cm shorter than the leg length in non-HCH populations. Sitting height increased from 39 cm at birth to 81 cm in adolescents, 7 cm below mean in non-HCH adolescents. Mean (range) adult height were 143.6 cm (131–154.5) and 130.8 cm (124–138) for males and females, respectively.

Conclusions

The disharmonic growth between the less affected trunk and the severely affected limbs determine body disproportion in HCH.

Acknowledgments

Thanks to patients and families.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Spranger JW, Brill P, Nishimura G, Superti-Furga A, Unger S. Bone dysplasias: an atlas of genetic disorders of skeletal development, 3rd ed. New York: Oxford University Press, 2012:11–4.10.1093/med/9780195396089.001.0001Search in Google Scholar

2. Bonafe L, Cormier-Daire V, Hall C, Lachman R, Mortier G, et al. Nosology and classification of genetic skeletal disorders: 2015 revision. Am J Med Genet A 2015;167A:2869–92.10.1002/ajmg.a.37365Search in Google Scholar PubMed

3. Thauvin-Robinet C, Faivre L, Lewin P, Monléon JD, François C, et al. Hypochondroplasia and stature within normal limits: another family with an Asn540Ser mutation in the fibroblast growth factor receptor 3 gene. Am J Med Genet A 2003;119A:81–4.10.1002/ajmg.a.10238Search in Google Scholar PubMed

4. Rousseau F, Bonaventure J, Legeai-Mallet L, Schmidt H, Weissenbach J, et al. Clinical and genetic heterogeneity of hypochondroplasia. J Med Genet 1996;33:749–52.10.1136/jmg.33.9.749Search in Google Scholar PubMed

5. Prinster C, Carrera P, Maschio MD, Weber G, Maghnie M, et al. Comparison of clinical-radiological and molecular findings in hypochondroplasia. Am J Med Genet 1998;75:109–12.10.1002/(SICI)1096-8628(19980106)75:1<109::AID-AJMG22>3.0.CO;2-PSearch in Google Scholar PubMed

6. Ramaswami U, Rumsby G, Hindmarsh P, Brook C. Genotype and phenotype in hypochondroplasia. J Pediatr 1998;133: 99–102.10.1016/S0022-3476(98)70186-6Search in Google Scholar PubMed

7. Fano V, Gravina LP, Pino MD, Chertkoff L, Barreiro C, et al. High specificity of head circumference to recognize N540K mutation in hypochondroplasia. Am J Med Genet A 2005;32:782–8.10.1080/03014460500268481Search in Google Scholar

8. del Pino M, Fano V. Height correlations between parents and offspring in achondroplasia population. Am J Med Genet A 2013;161:396–8.10.1002/ajmg.a.35721Search in Google Scholar

9. Lejarraga H, Heinrich J, Rodríguez A. Norms and techniques Anthropometric measures. Revista del Hospital de Niños 1975;17:176–81.Search in Google Scholar

10. Caíno S, Adamo P, Kelmansky D, Lejarraga H. Impact of training on the error of anthropometric measurements. Arch Argent Pediatr 2002;100:110–3.Search in Google Scholar

11. del Pino M, Orden A, Arenas M, Caino S, Fano V. Argentine references of sitting height and lower limb length from 0 to 18 years. Medicina infantil 2016;XXIII:279–86.Search in Google Scholar

12. Cole TJ. Fitting smoothed centile curves to reference data. J R Stat Soc Ser A Stat Soc 1988;151:385.10.2307/2982992Search in Google Scholar

13. Cole TJ, Green PJ. Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 1992;11:1305–19.10.1002/sim.4780111005Search in Google Scholar PubMed

14. Van Buuren S, Fredriks M. Worm plot: a simple diagnostic device for modelling growth reference curves. Stat Med 2001;20:1259–77.10.1002/sim.746Search in Google Scholar PubMed

15. Royston P, Wright E. Goodness-of-fit statistics for age-specific reference intervals. Stat Med 2000;19:2943–62.10.1002/1097-0258(20001115)19:21<2943::AID-SIM559>3.0.CO;2-5Search in Google Scholar PubMed

16. Lejarraga H, del Pino M, Fano V, Caino S, Cole T. Growth references for weight and height for Argentinean girls and boys from birth to maturity: incorporation of data from the World Health Organization from birth to 2 years and calculation of new percentiles and LMS values. Arch Argent Pediatr 2009;107:126–33.Search in Google Scholar

17. del Pino M, Orden A, Arenas M, Fano V. Argentine references for the assessment of body proportions from birth to 17 years of age. Arch Argent Pediatr 2017;115:234–40.10.5546/aap.2017.eng.234Search in Google Scholar PubMed

18. Saunders CL, Lejarraga H, Pino MD. Assessment of head size adjusted for height: an anthropometric tool for clinical use based on Argentinian data. Am J Med Genet A 2006;33:415–23.10.1080/03014460600742062Search in Google Scholar

19. Pinto G, Cormier-Daire V, Merrer ML, Samara-Boustani D, Baujat G, et al. Efficacy and safety of growth hormone treatment in children with hypochondroplasia: comparison with an historical cohort. Horm Res Paediatr 2014;82:355–63.10.1159/000364807Search in Google Scholar PubMed

20. Appan S, Laurent S, Chapman M, Hindmarsh PC, Brook CG. Growth and growth hormone therapy in hypochondroplasia. Acta Paediatr Scand 1990;79:796–803.10.1111/j.1651-2227.1990.tb11557.xSearch in Google Scholar PubMed

21. Bridges NA, Hindmarsh PC, Brook CG. Growth of children with hypochondroplasia treated with growth hormone for up to three years. Horm Res 1991;36:56–60.10.1159/000182190Search in Google Scholar PubMed

22. Tanaka N, Katsumata N, Horikawa R, Tanaka T. The comparison of the effects of short-term growth hormone treatment in patients with achondroplasia and with hypochondroplasia. Endocr J 2003;50:69–75.10.1507/endocrj.50.69Search in Google Scholar PubMed

23. Kanazawa H, Tanaka H, Inoue M, Yamanaka Y, Namba N, et al. Efficacy of growth hormone therapy for patients with skeletal dysplasia. J Bone Miner Metab 2003;21:307–10.10.1007/s00774-003-0425-7Search in Google Scholar PubMed

24. Mullis PE, Patel MS, Brickell PM, Hindmarsh PC, Brook CG. Growth characteristics and response to growth hormone therapy in patients with hypochondroplasia: genetic linkage of the insulin-like growth factor I gene at chromosome 12q23 to the disease in a subgroup of these patients. Clin Endocrinol 1991;34:265–74.10.1111/j.1365-2265.1991.tb03765.xSearch in Google Scholar

25. Massart F, Miccoli M, Baggiani A, Bertelloni S. Height outcome of short children with hypochondroplasia after recombinant human growth hormone treatment: a meta-analysis. Pharmacogenomics 2015;16:1965–73.10.2217/pgs.15.129Search in Google Scholar PubMed

26. Mugniery E, Dacquin R, Marty C, Benoist-Lasselin C, Vernejoul MD, et al. An activating Fgfr3 mutation affects trabecular bone formation via a paracrine mechanism during growth. Hum Mol Gen 2012;21:2503–13.10.1093/hmg/dds065Search in Google Scholar PubMed

27. del Pino M, Ramos Mejía R, Fano V. Leg length, sitting height, and body proportions references for achondroplasia: new tools for monitoring growth. Am J Med Genet A 2018;176:896–906.10.1002/ajmg.a.38633Search in Google Scholar PubMed

28. Meyer MF, Menken KU, Zimny S, Hellmich B, Schatz H. Pitfall in diagnosing growth hormone deficiency in a hypochondroplastic patient with a delayed puberty. Exp Clin Endocrinol Diabetes 2003;111:177–81.10.1055/s-2003-39780Search in Google Scholar PubMed

29. Hoover-Fong J, McGready J, Schulze K, Alade AY, Scott CI. A height-for-age growth reference for children with achondroplasia: expanded applications and comparison with original reference data. Am J Med Genet A 2017;173:1226–30.10.1002/ajmg.a.38150Search in Google Scholar PubMed

30. del Pino M, Fano V, Adamo P. Growth velocity and biological variables during puberty in achondroplasia. J Pediatr Endocrinol Metab 2018;31:421–8.10.1515/jpem-2017-0471Search in Google Scholar PubMed


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/jpem-2018-0046).


Received: 2018-01-24
Accepted: 2018-09-19
Published Online: 2018-10-18
Published in Print: 2018-11-27

©2018 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Original Articles
  3. Carotid intima media thickness and associations with serum osteoprotegerin and s-RANKL in children and adolescents with type 1 diabetes mellitus with increased risk for endothelial dysfunction
  4. Cardiometabolic risk factors in preschool children with abdominal obesity from Medellín, Colombia
  5. Long-term follow-up of gonadal dysfunction in morbidly obese adolescent boys after bariatric surgery
  6. Prevalence of overweight and obesity and anthropometric reference centiles for Albanian children and adolescents living in four Balkan nation-states
  7. High urate concentration is associated with elevated blood pressure in schoolchildren
  8. The association of hs-CRP and fibrinogen with anthropometric and lipid parameters in non-obese adolescent girls with polycystic ovary syndrome
  9. Leptin and adiposity as mediators on the association between early puberty and several biomarkers in European adolescents: the HELENA Study
  10. Adolescents with premenstrual syndrome: not only what you eat but also how you eat matters!
  11. Thyroid dysfunction in children with leukemia over the first year after hematopoietic stem cell transplantation
  12. Morning vs. bedtime levothyroxine administration: what is the ideal choice for children?
  13. Basal characteristics and first year responses to human growth hormone (GH) vary according to diagnostic criteria in children with non-acquired GH deficiency (naGHD): observations from a single center over a period of five decades
  14. The prevalence and volumetry of pituitary cysts in children with growth hormone deficiency and idiopathic short stature
  15. SHOX gene deletion screening by FISH in children with short stature and Madelung deformity and their characteristics
  16. FGFR3-related hypochondroplasia: longitudinal growth in 57 children with the p.Asn540Lys mutation
  17. Case Reports
  18. A variable course of Cushing’s disease in a 7 year old: diagnostic dilemma
  19. Severe hyperchylomicronemia in two infants with novel APOC2 gene mutation
Downloaded on 25.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2018-0046/html
Scroll to top button